In some countries, GLP-1 has been applied to the long-term treatment of clinical obesity, and GLP-1 can promote nerve growth and reduce neuroinflammation, which has become a hotspot in the research of neurodegenerative therapy (21). Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.